1. Home
  2. AMTD vs CGTX Comparison

AMTD vs CGTX Comparison

Compare AMTD & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMTD IDEA Group each representing six (6)

AMTD

AMTD IDEA Group each representing six (6)

HOLD

Current Price

$1.05

Market Cap

83.4M

Sector

N/A

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.29

Market Cap

94.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMTD
CGTX
Founded
2003
2007
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.4M
94.5M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
AMTD
CGTX
Price
$1.05
$1.29
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
6.1K
1.4M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.79
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$0.22
52 Week High
$1.65
$3.83

Technical Indicators

Market Signals
Indicator
AMTD
CGTX
Relative Strength Index (RSI) 46.18 63.65
Support Level $0.98 $1.01
Resistance Level $1.07 $1.54
Average True Range (ATR) 0.04 0.09
MACD -0.00 0.04
Stochastic Oscillator 30.00 85.20

Price Performance

Historical Comparison
AMTD
CGTX

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: